查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1667860

乌洛托品市场 - 全球产业规模、份额、趋势、机会和预测，按最终用途、按销售管道、按地区和竞争细分，2020-2035 年

Methenamine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By End-Use, By Sales Channel, By Region and Competition, 2020-2035F
出版日期: | 出版商: TechSci Research | 英文 183 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球乌洛托品市场价值为 502.72 万吨，预计到 2035 年将达到 740.94 万吨，预测期内年复合成长率(CAGR) 为 3.59%。

市场概况
预测期 2026-2035
2024 年市场规模 502.72 千吨
2035 年市场规模 740.94 千吨
2025-2035 年复合年增长率 3.59％
成长最快的领域 合成树脂
最大的市场 亚太地区

全球乌洛托品市场充满活力，并受到跨各行各业广泛应用的推动。六亚甲基四胺，也称为六亚甲基四胺，广泛用于药品、塑胶和消毒剂。在製药领域，它在治疗泌尿道感染（UTI）方面发挥关键作用，具有对抗特定细菌菌株的抗菌特性。根据世界卫生组织（WHO）的报告，细菌感染对常用抗生素的抗药性日益增强，导致需求增加。超过 60% 的淋病奈瑟菌分离株（性传染感染的主要原因）对广泛使用的抗生素环丙沙星表现出抗药性。此外，超过 20% 的大肠桿菌分离株（导致泌尿道感染的主要原因）对第一线（氨芐西林、复方新诺明）和二线（氟喹诺酮类）治疗均表现出抗药性。

主要市场驱动因素

製药领域对乌洛托品的需求不断成长

主要市场挑战

监管障碍和合规问题

主要市场趋势

乌洛托品生产技术进步

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：顾客之声

第 5 章：全球乌洛托品市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 依最终用途分类（合成树脂、橡胶工业、纺织业及其他）
    • 按销售管道（直接销售和间接销售）
    • 按公司分类（2024）
    • 按地区
  • 市场地图

第 6 章：北美乌洛托品市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美：国家分析
    • 墨西哥
    • 加拿大

第 7 章：欧洲乌洛托品市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲：国家分析
    • 德国
    • 英国
    • 义大利
    • 西班牙

第 8 章：亚太地区乌洛托品市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区：国家分析
    • 印度
    • 韩国
    • 日本
    • 澳洲

第九章：南美乌洛托品市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲：国家分析
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲乌洛托品市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA：国家分析
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章：市场动态

  • 驱动程式
  • 挑战

第 12 章：市场趋势与发展

  • 合併与收购（如有）
  • 产品发布（如果有）
  • 最新动态

第 13 章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 顾客的力量
  • 替代产品的威胁

第 14 章：竞争格局

  • Shandong Shengxuelong Chemical Co., Ltd.
  • UCC Shchekinoazot
  • Sina Chemical Industries Company
  • Henan Runhua Chemicals Co.,Ltd
  • Guangzhou Hanpu Pharmaceutical Co Ltd
  • Zaozhuang xudong chemical technology co., ltd.
  • Simalin Chemical Industries Private Limited

第 15 章：策略建议

第16章 调査会社について・免责事项

简介目录
Product Code: 27522

The global Methenamine market was valued at 502.72 thousand tonnes in 2024 and is projected to reach 740.94 thousand tonnes by 2035, registering a Compound Annual Growth Rate (CAGR) of 3.59% over the forecast period.

Market Overview
Forecast Period2026-2035
Market Size 2024502.72 Thousand Tonnes
Market Size 2035740.94 Thousand Tonnes
CAGR 2025-20353.59%
Fastest Growing SegmentSynthetic Resin
Largest MarketAsia- Pacific

The global Methenamine market is dynamic and driven by its broad range of applications across various industries. Methenamine, also known as hexamethylenetetramine, is widely used in pharmaceuticals, plastics, and as a disinfectant. In the pharmaceutical sector, it plays a critical role in treating urinary tract infections (UTIs), offering antimicrobial properties that combat specific bacterial strains. According to a World Health Organization (WHO) report, the growing resistance to common antibiotics in bacterial infections is contributing to increased demand. Over 60% of Neisseria gonorrhoeae isolates, a major cause of sexually transmitted infections, have shown resistance to ciprofloxacin, a widely used antibiotic. Additionally, more than 20% of E. coli isolates, a leading cause of UTIs, demonstrate resistance to both first-line (ampicillin, co-trimoxazole) and second-line (fluoroquinolones) treatments.

Key Market Drivers

Growing Demand for Methenamine in Pharmaceutical Applications

One of the main drivers of the global Methenamine market is its increasing use in the pharmaceutical industry, especially for its antimicrobial properties in treating UTIs. As UTIs remain one of the most common bacterial infections worldwide, the rising prevalence of these infections, particularly among women and the elderly, is fueling demand for Methenamine-based treatments. Methenamine is highly effective at preventing bacterial growth in the urinary tract and is frequently prescribed in combination with other drugs to enhance its therapeutic effects. In September 2024, Mankind Pharma Ltd. introduced its RAPID NEWS self-test kits to address prevalent health concerns such as UTIs, dengue, and early menopause. This innovation aims to make healthcare more accessible by offering individuals across India a convenient, private, and rapid testing solution.

Key Market Challenges

Regulatory Hurdles and Compliance Issues

The global Methenamine market faces significant regulatory challenges, which may hinder its growth. Methenamine, due to its classification as a chemical compound with multiple industrial applications, is subject to stringent regulations across different countries. These regulations primarily focus on safety standards, environmental impact, and potential risks to human health. Governments in regions such as the European Union, North America, and Asia Pacific have imposed limits on the manufacturing and use of chemicals like Methenamine due to concerns over their toxicity and environmental effects. Companies in this sector must navigate complex regulatory frameworks, including safety certifications, environmental approvals, and product registrations, which can delay time-to-market and increase operational costs. Additionally, the evolving nature of regulatory policies and the potential introduction of new laws add uncertainty to the market landscape.

Key Market Trends

Technological Advancements in Methenamine Production

Technological innovations in Methenamine production are driving the expansion of the global market. As demand for Methenamine grows across various industries, more efficient and cost-effective manufacturing processes are essential to meet market needs. New advancements in production technologies, such as sustainable manufacturing methods and improved reaction conditions, have significantly reduced production costs and increased output. This has made Methenamine more accessible to industries requiring large quantities of the compound.

Key Market Players

  • Shandong Shengxuelong Chemical Co., Ltd.
  • UCC Shchekinoazot
  • Sina Chemical Industries Company
  • Henan Runhua Chemicals Co., Ltd.
  • Guangzhou Hanpu Pharmaceutical Co. Ltd
  • Zaozhuang Xudong Chemical Technology Co., Ltd.
  • Simalin Chemical Industries Private Limited

Report Scope

This report segments the Global Methenamine Market into the following categories, along with detailed insights into industry trends:

Methenamine Market by End-Use:

  • Synthetic Resin
  • Rubber Industry
  • Textile Industry
  • Other Industries

Methenamine Market by Sales Channel:

  • Direct Sales
  • Indirect Sales

Methenamine Market by Region:

  • North America: United States, Canada, Mexico
  • Europe: France, United Kingdom, Italy, Germany, Spain
  • Asia-Pacific: China, India, Japan, Australia, South Korea
  • South America: Brazil, Argentina, Colombia
  • Middle East & Africa: South Africa, Saudi Arabia, UAE

Competitive Landscape

Company Profiles: In-depth analysis of the leading companies operating in the Global Methenamine Market.

Available Customizations:

The Global Methenamine Market report can be customized based on specific company needs. Customization options include:

  • Company Information: Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Methenamine Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By End-Use (Synthetic Resin, Rubber Industry, Textile Industry, and Others)
    • 5.2.2. By Sales Channel (Direct Sale and Indirect Sale)
    • 5.2.3. By Company (2024)
    • 5.2.4. By Region
  • 5.3. Market Map

6. North America Methenamine Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By End-Use
    • 6.2.2. By Sales Channel
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Methenamine Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By End-Use
        • 6.3.1.2.2. By Sales Channel
    • 6.3.2. Mexico Methenamine Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By End-Use
        • 6.3.2.2.2. By Sales Channel
    • 6.3.3. Canada Methenamine Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By End-Use
        • 6.3.3.2.2. By Sales Channel

7. Europe Methenamine Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By End-Use
    • 7.2.2. By Sales Channel
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Methenamine Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By End-Use
        • 7.3.1.2.2. By Sales Channel
    • 7.3.2. Germany Methenamine Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By End-Use
        • 7.3.2.2.2. By Sales Channel
    • 7.3.3. United Kingdom Methenamine Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By End-Use
        • 7.3.3.2.2. By Sales Channel
    • 7.3.4. Italy Methenamine Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By End-Use
        • 7.3.4.2.2. By Sales Channel
    • 7.3.5. Spain Methenamine Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By End-Use
        • 7.3.5.2.2. By Sales Channel

8. Asia-Pacific Methenamine Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By End-Use
    • 8.2.2. By Sales Channel
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Methenamine Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By End-Use
        • 8.3.1.2.2. By Sales Channel
    • 8.3.2. India Methenamine Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By End-Use
        • 8.3.2.2.2. By Sales Channel
    • 8.3.3. South Korea Methenamine Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By End-Use
        • 8.3.3.2.2. By Sales Channel
    • 8.3.4. Japan Methenamine Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By End-Use
        • 8.3.4.2.2. By Sales Channel
    • 8.3.5. Australia Methenamine Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By End-Use
        • 8.3.5.2.2. By Sales Channel

9. South America Methenamine Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By End-Use
    • 9.2.2. By Sales Channel
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Methenamine Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By End-Use
        • 9.3.1.2.2. By Sales Channel
    • 9.3.2. Argentina Methenamine Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By End-Use
        • 9.3.2.2.2. By Sales Channel
    • 9.3.3. Colombia Methenamine Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By End-Use
        • 9.3.3.2.2. By Sales Channel

10. Middle East and Africa Methenamine Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By End-Use
    • 10.2.2. By Sales Channel
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Methenamine Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By End-Use
        • 10.3.1.2.2. By Sales Channel
    • 10.3.2. Saudi Arabia Methenamine Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By End-Use
        • 10.3.2.2.2. By Sales Channel
    • 10.3.3. UAE Methenamine Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By End-Use
        • 10.3.3.2.2. By Sales Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Porters Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Shandong Shengxuelong Chemical Co., Ltd.
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. UCC Shchekinoazot
  • 14.3. Sina Chemical Industries Company
  • 14.4. Henan Runhua Chemicals Co.,Ltd
  • 14.5. Guangzhou Hanpu Pharmaceutical Co Ltd
  • 14.6. Zaozhuang xudong chemical technology co., ltd.
  • 14.7. Simalin Chemical Industries Private Limited

15. Strategic Recommendations

16. About Us & Disclaimer